One Capital Management LLC Purchases New Shares in Cognex Corporation $CGNX

One Capital Management LLC bought a new stake in Cognex Corporation (NASDAQ:CGNX) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 54,060 shares of the scientific and technical instruments company’s stock, valued at approximately $1,945,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. REAP Financial Group LLC purchased a new stake in shares of Cognex in the third quarter valued at $27,000. Geneos Wealth Management Inc. raised its stake in shares of Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 736 shares during the period. CIBC Private Wealth Group LLC raised its stake in shares of Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after acquiring an additional 327 shares during the period. Miller Global Investments LLC purchased a new stake in shares of Cognex in the fourth quarter valued at $39,000. Finally, Larson Financial Group LLC raised its stake in shares of Cognex by 202.7% in the fourth quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company’s stock valued at $40,000 after acquiring an additional 740 shares during the period. Hedge funds and other institutional investors own 88.12% of the company’s stock.

Insider Buying and Selling at Cognex

In other Cognex news, insider Mark Fennell sold 64,873 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the transaction, the insider owned 11,263 shares of the company’s stock, valued at approximately $755,184.15. This trade represents a 85.21% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Darren Marc Long sold 20,252 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the transaction, the vice president directly owned 3,990 shares in the company, valued at $264,696.60. This trade represents a 83.54% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 224,847 shares of company stock valued at $14,975,098. Company insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets

CGNX has been the topic of several recent analyst reports. Needham & Company LLC increased their target price on shares of Cognex from $67.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, May 8th. TD Cowen reissued a “buy” rating on shares of Cognex in a research note on Tuesday, February 17th. UBS Group set a $75.00 price target on shares of Cognex in a research note on Tuesday, May 26th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $75.00 price target on shares of Cognex in a research note on Thursday, May 7th. Finally, Stephens raised their price target on shares of Cognex from $65.00 to $75.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $70.43.

Cognex Stock Performance

NASDAQ CGNX opened at $66.08 on Wednesday. The company has a market capitalization of $11.00 billion, a price-to-earnings ratio of 78.67 and a beta of 1.52. The company’s 50-day simple moving average is $57.26 and its two-hundred day simple moving average is $47.77. Cognex Corporation has a one year low of $29.22 and a one year high of $71.90.

Cognex (NASDAQ:CGNX) last posted its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.09. The business had revenue of $268.44 million for the quarter, compared to the consensus estimate of $245.98 million. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The company’s revenue for the quarter was up 24.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.14 EPS. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Equities analysts expect that Cognex Corporation will post 1.41 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st will be given a dividend of $0.085 per share. The ex-dividend date of this dividend is Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. Cognex’s dividend payout ratio (DPR) is 40.48%.

Cognex Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.